Symposium: Correlation between Morphologic and Functional Changes Induced by Xenobiotics
A review of the biology and toxicologic implications of the induction of lysosomal lamellar bodies by drugs

https://doi.org/10.1016/0041-008X(89)90054-9Get rights and content

Abstract

Over 30 drugs of differing pharmacologic action are capable of inducing lamellar bodies of lysosomal origin in cells of animals and humans. The structures develop because of a drug-induced impairment in lysosomal phospholipid catabolism. Toxicity frequently accompanies the induction of these bodies. However, little information exists as to whether their development or presence is causally linked to the cellular or tissue dysfunction. This review examines the biological aspects of the induction of lysosomal lamellar bodies by drugs and considers the toxicologic implications of their presence in cells.

References (54)

  • H. Lüllmann et al.

    Lipidosis induced by amphiphilic cationic drugs

    Biochem. Pharmacol.

    (1978)
  • R. Lüllmann-Rauch et al.

    Fusion of storage lysosomes in experimental lipidosis and glycogenosis

    Exp. Mol. Pathol.

    (1987)
  • Y. Matsuzawa et al.

    Studies on drug-induced lipidosis: Subcellular localization of phospholipid and cholesterol in the liver of rats treated with chloroquine or 4,4′,bis(diethylaminoethoxy)diethyldiphenylethane

    J. Lipid Res.

    (1980)
  • J.H. Powell et al.

    In vitro response of rat and human kidney lysosomes to aminoglycosides

    Biochem. Pharmacol.

    (1982)
  • M.J. Reasor

    Drug-induced lipidosis and the alveolar macrophage

    Toxicology

    (1981)
  • M.J. Reasor et al.

    Recovery from chlorphentermine-induced phospholipidosis in rat alveolar macrophages: Morphological features

    Exp. Mol. Pathol.

    (1981)
  • R.M. Ridout et al.

    Influence of agents that alter lysosomal function of fetal mouse hearts recovering from anoxia and substrate depletion

    J. Mol. Cell. Cardiol.

    (1986)
  • J.K. Seydel et al.

    NMR studies on the molecular basis of drug-induced phopholipidosis-II. Interaction between several amphiphilic drugs and phospholipids

    Biochem. Pharmacol.

    (1976)
  • P. Somani et al.

    Amiodarone-associated changes in human neutrophils

    Amer. J. Cardiol.

    (1986)
  • W. Staubli et al.

    Some properties of myeloid bodies induced in rat liver by an antidepressant drug (maprotiline)

    Exp. Mol. Pathol.

    (1978)
  • P.C. Adams et al.

    Peripheral neutrophil inclusions in amiodarone treated patients

    Brit. J. Clin. Pharmacol.

    (1986)
  • S. Akeda

    A study on the lipidosis induced by a coronary vasodilator, 4,4′-diethylaminoethoxyhexestrol dihydrochloride

    Mie Med. J.

    (1972)
  • G. Aubert-Tulkens et al.

    Gentamicin-induced lysosomal phospholipidosis in cultured rat fibroblasts

    Lab. Invest.

    (1979)
  • L.J.A. DiDio

    The ubiquity of “myelin figures” as seen with electron microscopy

    Atenes Parmense Acta Biomed

    (1972)
  • J.V. Dingell et al.

    Species differences in the metabolism of imipramine and desmethylimipramine (DMI)

    J. Pharmacol. Exp. Ther.

    (1964)
  • D. Drenckhahn et al.

    Lysosomal alterations in cultured macrophages exposed to anorexigenic and psychotropic drugs

    Lab. Invest.

    (1976)
  • E.E. Essien et al.

    Effects of chloroquine and didesethylchloroquine on rabbit myocardium and mitochondria

    J. Pharm. Pharmacol.

    (1986)
  • Cited by (112)

    • Pathological Biomarkers in Toxicology

      2019, Biomarkers in Toxicology
    View all citing articles on Scopus

    Presented at the 27th Annual Meeting of the Society of Toxicology, Dallas, Texas, February 1988.

    View full text